J Seidenfeld

Summary

Affiliation: Blue Cross and Blue Shield Association
Country: USA

Publications

  1. ncbi request reprint Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis
    J Seidenfeld
    Blue Cross and Blue Shield Association Technology Evaluation Center, Chicago, Illinois 60601 7680, USA
    Ann Intern Med 132:566-77. 2000
  2. ncbi request reprint Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials
    J Seidenfeld
    Technology Evaluation Center, Blue Cross and Blue Shield Association, Chicago, IL 60601 7680, USA
    J Natl Cancer Inst 93:1204-14. 2001

Detail Information

Publications2

  1. ncbi request reprint Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis
    J Seidenfeld
    Blue Cross and Blue Shield Association Technology Evaluation Center, Chicago, Illinois 60601 7680, USA
    Ann Intern Med 132:566-77. 2000
    ..To compare luteinizing hormone-releasing hormone (LHRH) agonists with orchiectomy or diethylstilbestrol, and to compare antiandrogens with any of these three alternatives...
  2. ncbi request reprint Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials
    J Seidenfeld
    Technology Evaluation Center, Blue Cross and Blue Shield Association, Chicago, IL 60601 7680, USA
    J Natl Cancer Inst 93:1204-14. 2001
    ..Evidence is insufficient to determine whether initiating epoetin earlier spares more patients from transfusion or results in better quality of life than waiting until hemoglobin concentrations decline to nearly 10 g/dL...